What's Happening?
Piramal Pharma Solutions has acquired a Korsch XM-12 bilayer tablet press for its Morpeth, UK facility. This addition enhances the facility's capabilities in developing fixed dose combinations and modified release drug delivery. The XM-12 allows for high tablet output with precision and efficiency, supporting both single-layer and bilayer production. Comprehensive training protocols have been implemented to ensure safe operation and high-quality output.
Why It's Important?
The acquisition of the Korsch XM-12 tablet press is a strategic investment for Piramal Pharma Solutions, reinforcing its commitment to advancing drug delivery and patient-centric operations. This enhancement in formulation capabilities allows for the production of premium tablets at scale, which can lead to more innovative therapies and improved patient outcomes. It also demonstrates the company's dedication to continuous improvement and quality in pharmaceutical manufacturing.
